Patents Assigned to Atrix Laboratories, Inc.
  • Patent number: 5487897
    Abstract: The invention is directed to a biodegradable implant precursor having a two-part structure made of an outer sac and a liquid content. The implant precursor is composed of a biodegradable, water-coagulable thermoplastic polymer and a water-miscible organic solvent. When administered to an implant site in an animal, the implant precursor will solidify in situ to a solid, microporous matrix by dissipation of the organic solvent to surrounding tissue fluids and coagulation of the polymer. The invention also includes methods of making the implant precursor, an apparatus for forming the precursor, and a kit containing the apparatus. Also provided are methods of using the implant precursor for treating a tissue defect in an animal, for example, for enhancing cell growth and tissue regeneration, wound and organ repair, nerve regeneration, soft and hard tissue regeneration, and the like, for delivery of biologically-active substances to tissue or organs, and other like therapies.
    Type: Grant
    Filed: September 28, 1993
    Date of Patent: January 30, 1996
    Assignee: Atrix Laboratories, Inc.
    Inventors: Alan M. Polson, Deryl D. Swanbom, Richard L. Dunn, Charles P. Cox, Richard L. Norton, Bryan K. Lowe, Kenneth S. Peterson
  • Patent number: 5368859
    Abstract: Methods are described for assisting the restoration of periodontal tissue in a periodontal pocket and for retarding migration of epithelial cells along the root surface of a tooth. The methods involve placement of an in-situ forming biodegradable barrier adjacent the surface of a tooth. The barrier is microporous and includes pores of defined size. The barrier can include a biologically active agent.
    Type: Grant
    Filed: June 29, 1993
    Date of Patent: November 29, 1994
    Assignee: Atrix Laboratories, Inc.
    Inventors: Richard L. Dunn, Arthur J. Tipton, George L. Southard, Jack A. Rogers
  • Patent number: 5340849
    Abstract: A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a non-reactive polymer in biocompatible solvent to form a liquid, placing the liquid within the animal, and allowing the solvent to dissipate to produce the implant. An alternative, thermosetting system comprises mixing together effective amounts of a liquid acrylic ester terminated, biodegradable prepolymer and a curing agent, placing the liquid mixture within an animal and allowing the prepolymer to cure to form the implant. Both systems provide a syringeable, solid biodegradable delivery system by the addition of an effective level of biologically active agent to the liquid before injection into the body.
    Type: Grant
    Filed: December 23, 1991
    Date of Patent: August 23, 1994
    Assignee: Atrix Laboratories, Inc.
    Inventors: Richard L. Dunn, James P. English, Donald R. Cowsar, David D. Vanderbilt
  • Patent number: 5324519
    Abstract: The invention is directed to a composition composed of a thermoplastic or thermosetting polymer which is capable of forming a biodegradable and/or bioerodible microporous, solid or gelatinous polymer matrix. The matrix is useful as an implant in animals for enhancing regeneration of cells and tissue, such as bone and nerve cells, or for delivery of biologically-active substances to tissue or organs. The composition is administered to an implant site as a liquid. The invention also includes a method of preventing and treating disorders and diseases, such as bone or nerve growth disorders, or of altering body functions such as birth control, using the compositions and implants of the invention.
    Type: Grant
    Filed: October 28, 1991
    Date of Patent: June 28, 1994
    Assignee: Atrix Laboratories, Inc.
    Inventors: Richard L. Dunn, Arthur J. Tipton, George L. Southard, Jack A. Rogers
  • Patent number: 5278202
    Abstract: A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a non-reactive polymer in biocompatible solvent to form a liquid, placing the liquid within the animal, and allowing the solvent to dissipate to produce the implant. An alternative, thermosetting system comprises mixing together effective amounts of a liquid acrylic ester terminated, biodegradable prepolymer and a curing agent, placing the liquid mixture within an animal and allowing the prepolymer to cure to form the implant. Both systems provide a syringeable, solid biodegradable delivery system by the addition of an effective level of biologically active agent to the liquid before injection into the body.
    Type: Grant
    Filed: December 23, 1991
    Date of Patent: January 11, 1994
    Assignee: Atrix Laboratories, Inc.
    Inventors: Richard L. Dunn, James P. English, Donald R. Cowsar, David D. Vanderbilt
  • Patent number: 5278201
    Abstract: A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a non-reactive polymer in biocompatible solvent to form a liquid, placing the liquid within the animal, and allowing the solvent to dissipate to produce the implant. An alternative, thermosetting system comprises mixing together effective amounts of a liquid acrylic ester terminated, biodegradable prepolymer and a curing agent, placing the liquid mixture within an animal and allowing the prepolymer to cure to form the implant. Both systems provide a syringeable, solid biodegradable delivery system by the addition of an effective level of biologically active agent to the liquid before injection into the body.
    Type: Grant
    Filed: April 24, 1990
    Date of Patent: January 11, 1994
    Assignee: Atrix Laboratories, Inc.
    Inventors: Richard L. Dunn, James P. English, Donald R. Cowsar, David P. Vanderbilt
  • Patent number: 5133981
    Abstract: A method for separating and purifying individual benzophenanthridine alkaloids from alkaloid extracts by using the pH differences in formation of their respective alkanolamine or base forms and iminium ions. The insoluble base form of the alkaloid is collected as a precipitate and dissolved in an organic solvent and converted to the insoluble iminium ion form with a mineral or organic acid.
    Type: Grant
    Filed: November 17, 1989
    Date of Patent: July 28, 1992
    Assignee: Atrix Laboratories, Inc.
    Inventors: Ronald J. Harkrader, Richard R. Jones